XRNChiron Real Estate Inc.
Is the price fair?
Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Cheap vs its own history: P/E 9.2 vs a 39.4 median over 22 quarters (−77% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What XRN's price assumes
Chiron Real Estate Inc. trades at 9.19× earnings against 37.6× for the median REIT - Healthcare Facilities name, cheaper than its own group.
Trailing P/E · REIT - Healthcare Facilities median 37.6 · cheaper than the typical name in its group
- Price / sales
- 2.84
Price / sales · as of 2026-Q1
- Price / book
- 0.86
Price / book · as of 2026-Q1
- EV / sales
- 7.27
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.86
- EV / EBITas of 2026-Q1
- 31.1
- EV / salesas of 2026-Q1
- 7.27
- Real Estate median P/E130 names
- 24.6
- REIT - Healthcare Facilities median P/E11 names
- 37.6
- Market capitalisation
- $493M
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 9.19× today against a 39.4× median |
| 52-week range | $28.75 – $38.09 |
| Today | $34.11 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
REIT, Healthcare Facilities
The closest names by size in the same industry